Senior MSL – Hematology & APML, Phase III Trials

Alpha Clinical Development; Poland (ME); Hybrid; USD 90,000 - 130,000; Full time

Job summary

Alpha Clinical Development seeks an experienced Medical Science Liaison (MSL) to support ongoing Phase III clinical trials in hematologic malignancies, focusing on Acute Promyelocytic Leukemia (APML). The MSL will act as a bridge between the organization and key medical experts, providing scientific support, engaging with stakeholders, and disseminating clinical insights. With 5-8 years of relevant experience and an advanced degree required, this role involves travel and collaboration across various teams.

Qualifications

• 5 - 8 years of industry experience, including direct MSL or field-based Medical Affairs roles.
• Demonstrated experience supporting Phase III clinical trials.
• Strong background in hematologic malignancies or rare hematology; APML experience preferred.

Responsibilities

• Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals.
• Engage with KOLs to discuss clinical data and study progress.
• Provide medical and scientific support for ongoing Phase III clinical trials.
• Support clinical trial sites with protocol education and disease awareness.

Skills

Strong communication skills

Stakeholder engagement

Analytical skills

Education

Advanced degree (MD, PharmD, or PhD)

Job description

Alpha Clinical Development seeks an experienced Medical Science Liaison (MSL) to support ongoing Phase III clinical trials in hematologic malignancies, focusing on Acute Promyelocytic Leukemia (APML). The MSL will act as a bridge between the organization and key medical experts, providing scientific support, engaging with stakeholders, and disseminating clinical insights. With 5-8 years of relevant experience and an advanced degree required, this role involves travel and collaboration across various teams.